Autophagy and inflammsome: how are they related? by Mahú, Maria Inês Machado
  
Maria Inês Machado Mahú 
 
 
AUTOPHAGY AND INFLAMMSOME: 
 HOW ARE THEY RELATED? 
 
 
Mestrado em Investigação Biomédica 
2013 
 
  
 
Maria Inês Machado Mahú 
 
 
 
 
AUTOPHAGY AND INFLAMMSOME: HOW ARE THEY 
RELATED? 
 
 
Dissertação de Mestrado em Investigação Biomédica, na especialidade de Infecção e Imunidade 
apresentada à Faculdade de Medicina da Universidade de Coimbra para obtenção do grau de Mestre. 
 
 
 
Orientadores: Doutora Teresa Cruz e Doutor Henrique Girão 
 
 
Coimbra, 2013
 
3 
 
 
 
 
 
 
 
 
 
  
O trabalho apresentado nesta dissertação foi realizado no Centro de Oftalmologia e Ciências 
da Visão, Instituto de Imagem Biomédica e Ciências da Vida (IBILI) da Faculdade de Medicina 
da Universidade de Coimbra, sob a orientação da Doutora Teresa e do Doutor Henrique Girão, 
no âmbito do Mestrado de Investigação Biomédica (MIB) da Faculdade de Medicina da 
Universidade de Coimbra. 
Dedico esta tese à minha Aidinha. 
Da tua primeira, que te adora! 
 
5 
 
Agradecimentos: 
Este trabalho é meu, mas eu não sou mais que o resultado das pessoas que me 
rodeiam, portanto agradeço-lhes pelo papel que tiveram durante esta fase do meu 
percurso. 
 
Primeiro aos orientadores, claro, por me darem esta oportunidade e acreditarem que 
eu era capaz. Teresa e Henrique, além do vosso encorajamento e estímulo científico, 
agradeço essencialmente a vossa imensa compreensão e paciência para com: a 
demora nos resultados, as muitas teimosias, a terrível desorganização e a necessidade 
de “espaço” para manter o entusiasmo...por me aceitarem tal como sou e verem 
potencial onde eu não sabia que tinha. Cresci imenso com este processo ao vosso lado. 
Ajudaram-me a reconhecer as minhas falhas e virtudes. Levo-vos no pensamento para 
o resto do meu percurso na ciência. 
Aos colegas de trabalho com quem contactei diariamente durante esta experiência. 
Foram essenciais para que eu me sentisse confortável neste laboratório, nesta família 
científica que temas sido ao longo de muitos meses. Deste alguns merecem um 
agradecimento extra. Ahah! O João, meu companheiro de bancada, que me distraías e 
animavas com as nossas conversas sobre coisas “esquisitas” sobre outras ciências e 
sobre o mundo, enquanto eu fazia a milionésima variação da mesma experiência a ver 
se era “desta, que ia ter resultados”. A Teresinha, minha office-mate, minha inspiração 
de responsabilidade e sensatez, por partilhares as lutas e as frustrações deste percurso 
a meu lado, pela parceria nas choradeiras, pela nossa amizade. A minha Ana 
Margarida, soul-mate do meu coração, por compreenderes melhor que ninguém a 
loucura da minha essência e ainda assim a encorajares, não tenho palavras para 
descrever o teu contributo…aos nossos cigarrinhos. 
Depois a quem está longe… 
Aos amigos por me manterem a sanidade mental. Às meninas que me aliviavam as 
amarguras da vida laboratorial com risos e palhaçadas quando me levavam a dançar. E 
 ao Portinho, pelas conversas filosóficas que aligeiravam o peso da ciência na minha 
mente e me abriram os horizontes a outros mundos. Estar convosco era o meu prazer 
de fim-de-semana, a minha fonte especial de felicidade e tranquilidade, aquilo que me 
recarregava as baterias para voltar com energia ao trabalho difícil que me esperava 
todas as segundas-feiras. 
E finalmente, à mãe e ao Xico, porque deixar-vos orgulhosos foi essencial para a minha 
motivação naqueles dias em que nada resultava. Agradeço-te mãe, por sempre teres 
sido uma lutadora e me inspirares a tornar-me numa mulher tão independente e 
corajosa nas minhas batalhas como tu, e por acreditares que eu tenho o potencial para 
alcançar tudo o que sonho. Xico, obrigada por seres uma pessoa tão maravilhosa e me 
surpreenderes tanto com a tua maturidade, ser uma fonte de inspiração como irmã 
mais velha assim, é não só um privilégio como um desafio. Se tu és capaz de ser adulto 
sem perderes a tua doçura, eu só tinha de o ser também. 
i 
 
Table of contents 
 
Index of Figures: ...................................................................................................................... iii 
 
Abbreviations: .......................................................................................................................... v 
 
Resumo.....................................................................................................................................1 
 
Abstract: ...................................................................................................................................3 
 
Introduction ..............................................................................................................................5 
IL-1b......................................................................................................................................5 
Exosomes ..............................................................................................................................8 
Autophagy: ......................................................................................................................... 10 
 
Aim: ........................................................................................................................................ 13 
 
Materials and Methodology: ................................................................................................... 15 
 
Results .................................................................................................................................... 19 
 
Discussion: .............................................................................................................................. 31 
 
References: ............................................................................................................................. 35 
 
  
iii 
 
Index of Figures: 
Figure I – Example of IL-1b production activation after ligation of a TLR receptor by LPS 
and activation of the NLRP3 inflammasome by ATP.  
Figure II – Five major pathways of non-classical secretion by which the cytosolic IL-1b 
can be exported to the extracellular compartment  
Figure III – Endocytosis, exosomes and intercellular communication.  
Figure IV – Hypothetical model divergence between degradative and secretory 
autophagy as a result of the formation of different autophagosomes. 
Figure V –Autophagy induction favors fusion between autophagic vacuoles and MVBs. 
Figure 1 – Induction of exosome release after THP-1 treatment with LPS and ATP.  
Figure 2 – Induction of IL-1b production after THP-1 treatment with LPS and ATP.  
Figure 3 – Induction of IL-1b mRNA expression after THP-1 treatment with LPS and 
ATP. 
Figure 4 – Increase in IL-1b levels after exosome transfer.  
Figure 5 – Induction of the autophagic flux by rapamycin treatment in THP-1 cells.  
Figure 6 – Modulation of exosome release by autophagy induction, after 
inflammasome activation.  
Figure 7 – Modulation of IL-1b production by autophagy induction, after 
inflammasome activation.  
Figure 8 – Modulation of IL-1b mRNA levels by autophagy induction, after 
inflammasome activation.  
Figure S1 – Representative graph of flow cytometry analysis of exosome count change 
after THP-1 treatment with LPS and ATP, flowed by autophagy induction with 
rapamycin. 
  
  
v 
 
Abbreviations: 
Acb1 – acyl coenzyme A binding protein 1 (yeast) 
ATP – adenosine 5'-triphosphate 
CD 63 – cluster of differentiation 63 
CD 8+ – cluster of differentiation 8 positive  
CUPS – compartment for unconventional protein secretion 
DAMP – damage-associated molecular pattern 
DC – dendritc cell 
ELISA – enzyme-linked immunosorbent assay 
GAPDH – glyceraldehyde 3-phosphate dehydrogenase 
HMGB1 – high mobility group box 1 
IL-1 – interleukin 1 
IL-1b – interleukin 1 beta 
IL-18 – interleukin 18 
LC3 B – microtubule-associated protein 1 light chain 3 beta 
LPS – lipopolysaccharide 
MHC – major histocompatibility complex 
mRNA – messenger ribonucleic acid 
microRNA – micro-ribonucleic acid 
MVB – multivesicular body 
NLR – nod-like receptor 
NLRP3 – nod-like receptor family, pyrin domain containing 3 
PAMP – pathogen-associated molecular pattern 
RNA – ribonucleic acid 
RT-PCR – real-time polymerase chain reaction 
TLR – toll-like receptor 
WGA-PE – phycoerythrin- conjugated wheat germ agglutinin 
  
  
Resumo 
 
1 
Resumo 
Um número crescente de doenças tem vindo a ser associado à inflamação prolongada, 
muitas vezes ligada a um aumento dos níveis de IL-1b extracelular. Assim, a redução 
desta via pró-inflamatória tem sido sugerida como um importante alvo para terapias 
de protecção contra estas patologias. Contudo, encontrar um mecanismo eficaz para a 
inibição da secreção de IL-1b continua a ser um desafio neste campo de investigação. 
Tem sido amplamente demonstrado que esta citocina é exportada a partir de células, 
após a activação do inflamossoma, através de várias vias não-convencionais de 
secreção, incluindo por exossomas. Estas vesículas, que representam uma sub-classe 
específica de vesículas membranares provenientes da fusão de corpos multivesiculares 
com a membrana plasmática, foram isoladas de diversos fluidos corporais e a sua 
acumulação foi descrita em associação a uma variedade de doenças humanas. Os 
exossomas são veículos importantes para a comunicação intercelular, uma vez que 
permitem a entrega a longa distância de cargas efetoras. Portanto, no contexto da 
inflamação conduzida pela IL-1b, é razoável especular que estas vesículas sejam 
cruciais para a estimulação de células distantes e para a amplificação de respostas 
imunitárias. Para além da sua fusão com a membrana plasmática que resulta na 
libertação exossomas, os corpos multivesiculares também pode interagir com 
autofagossomas gerando um organelo híbrido denominado anfissoma, o qual pode 
subsequentemente fundir com o lisossoma (formando um autolisossoma) para 
degradar o material incorporado. Assim, é concebível sugerir que a estimulação da 
fusão com lisossomas constitua uma estratégia para a inibição da secreção de 
exossomas. Um dos mecanismos que é conhecido por promover essa fusão é 
autofagia. 
Tomados em conjunto, estes dados levaram-nos a investigar o papel da indução de 
autofagia como um mecanismo para modulador da libertação de exosomes contendo 
IL-1b pela linha celular monocítica THP-1, depois da activação do inflamossoma. 
Começámos por demonstrar que a activação do inflamossoma, depois da incubação 
com LPS ou LPS e ATP, em células THP-1 induz a secreção de exosomes contendo não 
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só a citocina IL-1b, mas também o seu ARNm. Além disso, a incubação de células não 
estimuladas com essas vesículas levou a um aumento da resposta pró-inflamatória 
sem qualquer outro estímulo imunológico. Finalmente, verificou-se que a estimulação 
da actividade autofágica pela rapamicina em células THP-1, previamente activadas 
com LPS e ATP, foi capaz de inibir tanto a libertação de exossomas como os níveis 
totais de IL-1b (proteína e ARNm) produzidos e secretados para exterior. 
De acordo com o nosso conhecimento, os resultados obtidos neste estudo mostram, 
pela primeira vez, que a indução da autofagia pode ter um efeito anti-inflamatório 
através da inibição da libertação e posterior propagação de exossomas contendo IL-1b. 
No seu conjunto, os resultados obtidos no presente estudo, não só constituem uma 
contribuição importante para o estudo dos mecanismos envolvidos nas respostas 
inflamatórias, mas também para o campo da biologia celular em geral, amplificando o 
conhecimento sobre os mecanismos envolvidos na secreção através exosomes. 
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Abstract: 
A growing number of diseases have been established to be linked to prolonged or 
exacerbated inflammation, often associated with increased levels of extracellular IL-1b. 
Hence, reducing this pro-inflammatory pathway has been suggested as a major target 
for protective therapies in these pathologies. However finding an effective mechanism 
for the inhibition of IL-1b secretion remains a challenge in the field. It has been 
extensively demonstrated that this cytokine is exported from cells, upon activation of 
the inflammasome, through several unconventional secretory pathways, including via 
exosomes. These vesicles, which represent a specific subclass of membrane vesicles 
originated from the fusion of multivesicular bodies (MVBs) with the plasma 
membrane, have been isolated from many body fluids and were described to 
accumulate in association with a variety of human diseases. Exosomes are important 
vehicles for intercellular communication, since they allow long-distance delivery of 
effector cargo. Therefore, in the context IL-1b driven inflammation, it is reasonable to 
speculate that those vesicles would be crucial for the stimulation of distant cells and 
the amplification of immune responses. Besides their fusion with the plasma 
membrane resulting exosome release, MVBs can also interact with autophagosomes 
generating a hybrid organelle termed amphisome, which may subsequently fuse with 
lysosomes (forming an autolysosome) to degrade the incorporated material. 
Therefore, it is conceivable to suggest that stimulating the fusion with lysosomes 
constitutes a strategy to prevent exosome secretion. One of the mechanisms that is 
known to promote such fusion is autophagy. 
Taken together, this information led us to explore the role of autophagy induction as a 
modulatory mechanism for the release of IL-1b-containing exosomes by the monocytic 
cell line THP-1, after inflammasome activation. We started by demonstrating that 
activation of the inflammasome, after incubation either with LPS or LPS and ATP, in 
THP-1 cells up-regulates the secretion of exosomes containing the not only IL-1b 
cytokine but also its mRNA. Moreover, incubation of unstimulated cells with these IL-
1b-containg vesicles led to the amplification of the pro-inflammatory response without 
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any other immune challenge. Finally, we found that in THP-1 cells, previously activated 
with LPS and ATP, the stimulation of autophagic activity by rapamycin was able to 
inhibit both release of exosomes and total levels of IL-1b (protein and mRNA) 
produced and secreted. 
According to our knowledge, the results obtained in this study show, for the first time, 
that induction of autophagy may have an anti-inflammatory effect by inhibiting the 
release and further spreading of IL-1b-containing exosomes. Altogether, the results 
obtained in this study constitute not only an important contribution for the study of 
the mechanisms involved in inflammatory responses, but also for the field of cell 
biology in general, broadening our understanding of the mechanisms involved in 
secretion through exosomes. 
Introduction 
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Introduction 
IL-1b 
More than any other cytokine family, the IL-1 family of ligands and receptors is 
primarily associated with acute and chronic inflammation1. In that way, microbial 
invasion and tissue injury activate innate immune cells and promote overexpression 
and secretion of pro-inflammatory cytokines, such as Il-1b which is particularly known 
to evoke a constellation of host responses within hours or days after the recognition of 
“danger” signals. Hence, this cytokine regulates systemic and local responses to 
immunological challenges by generating fever, activating lymphocytes and promoting 
leukocyte transmigration into sites of injury or infection2.  
However, although these processes are meant to protect the body from insults, 
prolonged or exacerbated inflammatory responses associated with increased levels of 
extracellular IL-1b, have been linked to a growing number of diseases. Augmented IL-
1b production has been found in patients with viral, bacterial, fungal and parasitic 
infections. Increased IL-1b levels have also been related to atherosclerosis, type2 
diabetes and various autoimmune disorders, such as rheumatoid arthritis, multiple 
sclerosis and Crohn’s disease. Neurodegenerative diseases that are accompanied by 
inflammatory processes, such as Alzheimer’s disease or Parkinson’s disease, have also 
been characterized by augmented IL-1b production3.  
 
IL-1b production 
The cytokine IL-1b is known to be primarily produced by cells of the monocytic lineage, 
including monocytes, macrophages and dendritic cells. Its production and release are 
induced by a wide variety of stimuli, which can be divided into pathogen-associated 
molecular pattern molecules (PAMPs) and damage-associated molecular pattern 
molecules (DAMPs). For example, invading microorganisms are recognized through 
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PAMPs, such as lipopolysaccharide (LPS), while DAMPs, such as ATP, are endogenous 
ligands released by damaged or dying cells. Triggering signals mediated by recognition 
of PAMPs and DAMPs involve the activation of membrane-associated toll-like 
receptors (TLRs) or cytosolic nucleotide binding and oligomerization domain (nod)-like 
receptors (NLRs), respectively4. In turn, once activated, NLRs induce the assembly of 
multiprotein complexes called inflammasomes that trigger innate immune defenses 
through the maturation and secretion of IL-1b (fig. 1). 
 
 
Indeed, there is in fact a large body of experimental evidence demonstrating that serial 
treatment of cells with LPS and ATP provides a very powerful stimulus to induce rapid 
and efficient release of IL-1b from monocytes, macrophages and dendritic cells (DCs) 
5,6,7.  
 
IL-1b secretion 
In general, secretion of proteins can occur through classical or non-classical secretory 
pathways. Since, IL-1b lacks a conventional hydrophobic signal sequence for classical 
externalization and this so called leaderless protein is released through a non-classical 
Figure I – Example of IL-1b production activation after ligation of a TLR receptor by LPS and activation 
of the NLRP3 inflammasome by ATP. (Adapted from Wolff, 2011) 
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secretory pathway (also termed unconventional secretion) independent of 
endoplasmic reticulum and Golgi apparatus. Five different models of the mechanisms 
of IL-1b release have been proposed: (i) exocytosis of secretory lysosomes that 
accumulate cytosolic IL-1b via undefined protein transporters; (ii) release of 
membrane-delimited microvesicles derived from plasma membrane blebs formed by 
evaginations; (of the surface membrane that entrap cytosolic IL-b); (iii) release of 
membrane-delimited exosomes secondary to the exocytosis of multivesicular bodies 
formed by invaginations of recycling endosomes that entrap cytosolic IL-b; (iv) 
exocytosis of autophagosomes or autophagolysosomes that accumulate cytosolic IL-1b 
via entrapment during formation of the initial autophagic isolation membrane or 
omegasome and (v) direct release of cytosolic IL-1b secondary to regulated cell death 
by pyroptosis or necroptosis8 (fig. 2). 
 
Although the various stimuli and mechanisms for IL-1b release have been increasingly  
Lastly, it is important to note that even though the stimuli and the mechanisms that 
lead to IL-1b secretion are well characterized, finding an effective way of reducing this 
Figure II – Five major pathways of non-classical secretion by which the cytosolic IL-1b can be exported 
to the extracellular compartment: secretory autophagosomes, MVBs, microvesicle shedding, secretory 
lysosomes and membrane transporters. (Adapted from: Duitman et al, 2011) 
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pro-inflammatory pathway is still a major challenge. On this regard, one can speculate 
that interfering with the specific release of IL-1b-containing vesicles might be a more 
powerful approach to modulate systemic inflammatory pathologies, since it would 
reduce the stimulation of distant cells and therefore the amplification of immune 
responses. 
 
Exosomes 
Intercellular communication is an essential hallmark of multicellular organisms and can 
be mediated through direct cell–cell contact, secretion of molecules which then bind 
to receptors on surrounding cells or release of membrane vesicles that allow long-
distance delivery of effector cargo9. Exosomes represent a specific subclass of such 
membrane vesicles and their production is initiated when cell membrane proteins 
transfer to early endosomes by inward budding (Fig. 3). In early endosomes, molecules 
can be either recycled to the plasma membrane or incorporated into internal vesicles, 
commonly called multivesicular bodies (MVBs). These vesicles are formed when the 
limiting membranes of endosomes invaginate and bud into the lumen of the vesicle. 
During this process, several proteins can be sorted into the forming vesicles. In the 
degradation pathway, the MVBs fuse with lysosomes, but for exosome production, the 
MVBs fuse with the plasma membrane and consequently release the produced vesicles 
into the extracellular milieu as exosomes10 (Fig. 3).  
Since their discovery almost 30 years ago, exosomes have been isolated from several 
body fluids and were described to accumulate in association with a variety of diseases. 
Additionally, it was also found that cells can tightly regulate the secretion and 
molecular composition of these vesicles in response to different stimuli. More 
recently, these vesicles were shown to be able to deliver functional RNA (both 
messenger and microRNA) to target cells, suggesting the existence of a transfer of 
genetic information between cells, and thus elevating their role in the induction, 
amplification and/or modulation of pathological processes11. 
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Immunologist’s interest in exosomes came from the discovery in 1996 that cells of the 
immune system, B lymphocytes, were able to secrete exosomes by fusion of MVBs 
with the plasma membrane. Exosomes secreted by these cells harbor MHC class II 
dimers bound to antigenic peptides, molecules essential for the adaptive immune 
response. These exosomes were also shown to present the MHC–peptide complexes 
to specific T cells, suggesting that they could play a role in adaptive immune 
responses12. Two years later, the groups of Raposo, Amigorena and Zitvogel13 showed 
that DCs also secrete exosomes bearing functional MHC class I–peptide complexes, 
which could promote induction of CD8+ T-lymphocyte-dependent antitumor immune 
responses in mice in vivo. These results set the basis for the exploration of exosome 
trafficking and cargo characterization in the context of immune responses to cancer, as 
they can constitute powerful vehicles for anti-tumoural therapies14. However the role 
of exosomes in the modulation of inflammatory responses and innate immunity 
Figure III - Endocytosis, exosomes and intercellular communication. MVBs can either fuse with 
lysosomes to degrade their cargo, or with the plasma membrane to release their intra-luminal vesicles 
as exosomes. Exosomes can locally mediate intercellular signaling or at distant sites when secreted into 
the blood stream. (Adapted from: Ludwig et al, 2012) 
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processes has been left on the sidelines of scientific interest and is still very much 
underexplored, despite their previously mentioned role in the secretion of pro-
inflammatory cytokine IL-1b after inflammasome activation. 
 
Autophagy: 
Autophagy and exocytosis can have opposing or synergistic roles in cell function. For 
example, during times of reduced nutrient availability, autophagy is stimulated, 
allowing cells to recycle cytoplasmic components, and exocytosis is reduced to 
conserve cellular constituents and energy. In response to several stimuli, specialized 
secretory cells divert energy utilization towards the exocytic pathway. Conversely, 
when a cell is presented with an immune challenge, both exocytosis and autophagy 
can be up-regulated; exocytosis for the release of immune response factors and 
autophagy to clear invading pathogens from cells15. 
 
Degradative/secretory Autophagy 
Autophagy is a degradation mechanism in which a cupped-shape structure, also 
referred to as omegasome, isolation membrane or pre-autophagosome, encloses a 
portion of cytoplasm or even organelles, forming a double-membraned vacuole called 
autophagosome. To carry out degradative functions, autophagosomes fuse with 
lysosomes to form autolysosomes where the captured cargo is eventually degraded16. 
However, the notion of autophagy as a purely degradative pathway was recently 
challenged by the emergence of three independent reports on the role of autophagy in 
unconventional secretion of Acb1 in yeast and IL-1b and other cargo (e.g. HMGB1 and 
IL-18) in mammalian cells. These new insights assign a non-degradative function to 
autophagy manifested as unconventional protein secretion17 (fig. 4).  
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Here, a membrane structure, termed compartment for unconventional protein 
secretion (CUPS) has been identified as the source of organelles or trafficking 
intermediates for autophagy-based unconventional secretion. It is still unknown if this 
CUPS, the term used in yeast, is related to the mammalian cell omegasome, which acts 
as a cradle for generating nascent autophagosomes normally associated with 
degradative autophagy20.. 
 
 
Nonetheless, it was already shown that although serum starvation induces both CUPS 
and omegasomes, CUPS is reportedly not induced by rapamycin, which suggests that it 
is probably distinct from omegasomes18. 
 
Autophagy and MVBs 
Autophagosomes can also interact with MVBs, generating a hybrid organelle termed 
amphisome. Subsequently, the amphisome fuses with lysosomes (forming an 
Figure IV – Hypothetical model divergence between degradative and secretory autophagy as a result of 
the formation of different autophagosomes. (Adapted from Jiang et al, 2013) 
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autolysosome) to degrade the incorporated material19. However, as previously 
referred, in some conditions, MVBs are diverged for fusion with the plasma membrane 
where they release their intraluminal vesicles into the extracellular compartment as 
exosomes (fig. 5). 
 
 
 
Even though the convergence between the endocytic and the autophagic pathways 
has been widely characterized, and the morphological evidences suggest that MVBs 
are the main endocytic fusion partners that meet with the autophagosome, this 
process remains much underexplored as a means of modulating exosome secretion. 
There was, however, a report in 2008 by Colombo et al. where they presented 
evidence that in K562, a cell type that secretes exosomes through fusion of MVBs with 
the plasma membrane, autophagy induction caused fusion of these endocytic 
compartments with autophagic vacuoles. Interestingly, their results indicated that the 
convergence between MVBs and autophagosomes stimulated by autophagy induction 
also inhibited exosome secretion in all the conditions analyzed20. 
Figure V –Autophagy induction favors fusion between autophagic vacuoles and MVBs. The model 
proposes that autophagy induction promotes the fusion between autophagic vacuoles and MVBs the 
amphisome, which finally fuses with the lysosomal enzyme-containing compartment. (Adapted from: 
Fader et al, 2008) 
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Aim: 
Inflammation is widely recognized to be at the root of a host of serious human 
diseases from heart disease to diabetes and cancer. Acute inflammation occurs in 
response to pathogen attack (infection) or tissue injury and almost always involves 
inflammasome activation, a process that is supposed to clear up when the injury or 
infection is resolved. However, persistent inflammatory stimuli or dysfunction of the 
resolution phase results in chronic inflammation, which is known to underlie the 
development of various diseases.  
Consequently, finding anti-inflammatory approaches capable of silencing these 
exacerbated immune responses is certainly an important step towards finding efficient 
therapies for such diseases. On that account, it is reasonable to speculate that the 
release of pro-inflammatory mediators via membrane vesicles, such as exosomes, 
might be able to induce systemic inflammation more potently, thus elevating this 
pathway of secretion as an important target for the referred anti-inflammatory 
therapies.  
One of those pro-inflammatory mediators that is both secreted inside exosomes and 
also related to many diseases associated with increased inflammation is IL-1b. This 
cytokine is known to evoke a constellation of host responses after the recognition of 
“danger” signals by the inflammasome, being one of the major cytokines responsible 
for the regulation of systemic and local responses to immune challenges. Therefore, 
here we proposed to investigate a mechanism capable of dampening the secretion of 
IL-1b-containing exosomes after inflammasome activation.  
For that, we started by examining if the monocytic cell line THP-1 released exosomes 
upon stimulation with classic inflammasome activators and evaluated the vesicles’ 
cargo on their levels of IL-1b (for both protein and mRNA). Then, we confirmed that 
those exosomes isolated from the culture medium of activated cells were indeed 
functional in the amplification of the pro-inflammatory response when transferred to 
the culture of unstimulated cells inducing their production of IL-1b without any other 
Introduction 
 
14 
immune activation signal. Finally, the activation of autophagy was investigated as a 
means of lowering IL-1b levels and reducing exosome release by THP-1 cells after 
inflammasome activation. 
Materials and Methology 
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Materials and Methodology: 
Cell Culture 
FBS (fetal bovine serum) (Invitrogen) used for cell culture was ultracentrifuged at 
100,000 g for 16 h to remove exosomes present in FBS. THP-1, a human monocytic cell 
line derived from an acute monocytic leukemia (ATCC, TIB-202TM) was cultured in 
RPMI 1640 medium (Invitrogen) supplemented with 10% FBS, 0.05 mM β-
mercaptoethanol and standard antibiotics (100 units/ml penicillin and 100 g/ml 
streptomycin), in 37ºC, 5% CO2 in air incubator. 
For autophagic flux assay 2 x 106 cells were cultured per condition. To induce 
autophagy, rapamycin was added to the cultures at a concentration of 200 nM for 
either 1h or 3h. To evaluate autophagic flux cells were treated in the absence or 
presence of chloroquine (100 µM) to inhibit autophagosome-lysosome fusion, for the 
last 30 min of culture. 
For inflammasome activation experiments 7,5 x 106 cells were cultured per condition. 
Cells were incubated with 200 ng/mL of LPS for 6h and 1 mM of ATP was added for the 
last 30 min before harvesting. After the immune stimuli, cells were washed with PBS 
and replated in fresh medium with or without 200 nM of rapamycin, for 1h or 3h 
additional hours.  
For the exosome-conditioning assay, 2 x 106 cells were incubated with or without the 
addition to the culture medium of exosomes isolated from the supernatant of 1,5 x 107 
cells incubated with LPS and ATP as described above. Exosomes were added at three 
different time points (0, 3, 6 h) and cultured for 24h. 
 
Exosomes isolation 
Exosomes secreted by THP-1 monocytes were isolated from the culture media by two-
step centrifugation, always at 4ºC: The first step, at 15,000 g for 20min to remove 
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microvesicles and cell-debris, and then the collection step at 100,000 g for 1h. In the 
end the exosome rich pellet was either resuspended in 1mL of Trizol (Invitrogen Life 
Technologies) for RNA extraction or 200µL of cold phosphate saline buffer (PBS) and 
then stored at 4ºC for further analysis by western blot, flow cytometry and ELISA. 
 
Western blot 
After harvest, cells were washed with cold PBS, then lysed with 150µL of RIPA buffer, 
vortex vigorously 2-3 times and incubated on ice for 45 min. After centrifugation at 
16,000 g for 10 min at 4°C, the lysate supernatants were mixed with Laemmli Buffer, 
boiled at 95°C for 10 min and then sonicated (3 pulses of 15 sec). For LC3 B flux 
analysis, 45µL of each sample were resolved on 15% SDS-acrylamide gel and 
transferred to 0.2 μm nitrocellulose membranes. Exosome samples (obtained from the 
supernatant of 1,5 x 107 cells incubated with LPS and ATP as described above) were 
mixed with Laemmli Buffer and boiled at 95 °C. 50µL of exosome samples and 45µL of 
cell samples were resolved on 10% SDS-acrylamide gel and transferred to 0.2 μm 
nitrocellulose membranes. The membranes were blocked with 5% skim milk in TBS-T 
for 45 min, then incubated with anti-LC3 B (Cell Signaling Techonolgy) or anti-CD63 
(Santa Cruz) primary antibodies at a dilution of 1:500 in TBST containing 5% skim milk 
for 12 h at 4°C. Then, the membranes were washed three times with TBST, incubated 
with HRP-conjugated secondary antibodies (Bio-Rad Laboratories, Inc.) at a dilution of 
1:5000 in TBST containing 5% skim milk for 2 h, and then washed three times with 
TBST. Membranes were stripped and re-probed with anti-GAPDH antibody (SICGEN), 
to demonstrate equivalent protein loading, or anti-Lamin B antibody (Oncogene 
Research Products), to confirm that exosome samples were not contaminated with cell 
debris. The immuno-positive bands were visualized by enhanced chemi-luminescence. 
Densitometry was performed using VersaDoc (Bio-Rad).  
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RNA extraction and RT-PCR 
Total RNA was extracted from cells and exosomes samples using Trizol according to 
manufacturer's protocols (Invitrogen Life Technologies). The RNA was eluted in RNA 
storage solution (Ambion) and stored at −80° until RT-PCR analysis. Nucleic acid 
concentrations were measured by spectrophotometry.  
RT-PCR assay was performed using the two-step method. For the first-step of reverse 
transcription, we used iScript™ cDNA Synthesis Kit (Bio-Rad) with 1 µg of total RNA as 
template RNA, following the manufacturer's procedure. For the second step of real 
time PCR reactions, we employed SYBR® Green Supermix (Bio-Rad) and Primer Assays 
for human IL-1b and GAPDH according to manufacturer's protocol described for the 
iQ5 Real-Time PCR Detection System (Bio-Rad). PCR data obtained by the IQ5 Optical 
System were automatically analyzed by the IQ5 Optical System Software (Bio-Rad) and 
expressed as target/reference ratio. Our approach was based on the calibrator-
normalized relative quantification including correction for PCR efficiency of each gene. 
 
ELISA 
Total IL-1b concentration in cell culture supernatants and exosomes was determined 
by sandwich ELISA (Quantikine assay; R&D). Intracellular IL-1b was obtained from cells 
that were first washed with PBS, and then lysed with 2 M NaCl, 1% Triton X100, pH 5.5. 
The lysate was centrifuged at 16,000 g for 15min at 4ºC and then added directly to the 
microtiter wells. The concentrations of intracellular IL-1b were analyzed as described 
above.  
 
Flow-cytometry 
Exosome preparations were incubated with 25 µl of 4.5-µm-diameter Dynabeads® 
Human CD63 (Invitrogene) for 22h at 4ºC, then washed using a magnetic separator 
Materials and Methology 
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(Magna GrIP™ Rack, Milipore) and resuspended into 300 µl PBS. For the staining 
procedure the mixtures of beads and exosome-coated beads were incubated at room 
temperature for 1h with wheat germ agglutinin (WGA)-FICT (Sigma-Aldrich) and 
analyzed on a FACSCalibur flow cytometer (BD Biosciences). 
 
Statistical analysis  
The results are presented as mean ± S.D., and the statistic difference between two 
groups was determined by the two-sided unpaired Student’s t test. The tests were 
performed using GraphPad Prism, version 5.02 (GraphPad Software).  Statistically 
significant values are as follows: *p <0.05, **p <0.01, ***p <0.001. 
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Results 
It is known that some specialized cells can tightly regulate the secretion of a class of 
membrane vesicles of endosomal origin called exosomes in response to different 
stimuli. Although, it was already established that cells of the immune system release 
exosomes upon inflammatory challenge, however the regulation of this secretory 
mechanism is still very unclear. A main objective of this study is to investigate the 
release of exosomes in the context inflammasome activation using the monocytic cell 
line THP-1.  
In order access that we were able to perform successfully the exosome isolation 
protocol by ultra-centrifugation method and that the samples we then examined were 
not contaminated with cell debris, we started by incubating the cells with LPS followed 
by ATP, which is a classic stimulus for inflammasome activation, and access the 
isolated exosome samples by western blot for the presence of the protein commonly 
enriched in these vesicles tetraspanin CD63, and the absence of the nuclear protein 
Lamin B (Fig. 1 – A). 
Flow cytometric analysis of exosomes attached to anti-CD63 magnetic beads showed 
that activation of the inflammasome was indeed a powerful stimulus to boost the 
secretion of exosome. In fact, LPS alone was sufficient to induce an increase in the 
number of vesicles released to the extracellular medium, however the addition of ATP 
(1mM) for just the last 30 min of culture proved to be a much more powerful stimulus, 
promoting more than 2 fold-change in exosome counts (Fig. 1 – B). 
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Figure 1 – Induction of exosome release after THP-1 treatment with LPS and ATP. THP-1 cells were 
incubated for 6h with 200 ng/mL LPS in the presence or in the absence of 1mM of ATP for the last 30 
min of culture. Exosomes were isolated from culture medium by ultra-centrifugation method, as 
described above. (A) Western blot analysis of representative samples of cells and of exosomes isolated 
from the culture medium by the ultra-centrifugation method; (B) Fold-change in exosome counts 
relative to the control analyzed by flow cytometry. Exosomes were captured by anti-CD63 magnetic 
beads and stained with plasma membrane marker WGA-PE. Data represents the means of fold 
induction ± S.D. relatively to control, for three independent experiments. Statistically significant values 
compared to control are as follows: *p <0.05, ***p <0.001. 
 
It is known that IL-1b is primarily produced by cells of the monocytic lineage upon 
activation of the inflammasome, and that this pro-inflammatory cytokine is secreted 
by a variety of non-classical secretory pathways8. Here we investigated and quantified 
the production (intracellular) and release (total and via exosomes) of IL-1b by THP-1 
cells after incubation with either LPS or LPS and ATP using an ELISA assay (Fig. 2). 
As expected, when treated with LPS alone, THP-1 monocytes show an up-regulation of 
IL-1b synthesis and consequent secretion, and the combined treatment with ATP 
further induces that production. However, although we could clearly identify an 
increase in exosomes release after addition of ATP to the cell culture (Fig. 1 – B), that 
increase, surprisingly, was not associated with cytokine levels in the vesicles, remaining 
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practically the same in both conditions (Fig. 2 – EXO). This result suggests that each 
exosome can carry less IL-1b. 
 
 
 
 
 
 
 
 
Figure 2 – Induction of IL-1b production after THP-1 treatment with LPS and ATP. THP-1 cells were 
incubated for 6h with 200 ng/mL LPS  in the presence or in the absence of 1mM of ATP for the last 30 
min of culture. Intracellular (cells), total release to the medium (TM) and secretion via exosomes (EXO) 
of the pro-inflammatory cytokine IL-1b were determined by ELISA. Data represents the means of fold 
induction ± S.D. relatively to control, for three independent experiments. Statistically significant values 
compared to control are as follows: *p <0,05, **p <0,01, ***p <0,001. 
 
Recent studies demonstrated that exposure of human microvascular endothelial cells 
to several stress conditions alter RNA content of exosomes released by these. This data 
suggests that stress related signaling via exosomes does not only occur through 
protein transfer but also through shuttling of RNA21.  
Additionally, it has been established that incubation with LPS, followed or not by ATP, 
results in up-regulation of IL-1b mRNA expression by monocytic cells4. Together these 
observations led us to propose that the exosomes secreted by THP-1 monocytes might 
also carry not only the protein but also IL-1b mRNA. To access this question, we 
evaluated the expression of IL-1b mRNA, by RT-PCR, both intracellularly and in 
exosomes isolated from cells cultured either with LPS or LPS and ATP. 
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Figure 3 – Induction of IL-1b mRNA expression after THP-1 treatment with LPS and ATP. THP-1 cells 
were incubated for 6h with 200 ng/mL LPS in the presence or in the absence of 1mM of ATP for the last 
30 min of culture. RT-PCR results of induction of IL-1b mRNA levels in cells and in exosomes (EXO) 
isolated from culture. Data represents the means of fold induction ± S.D. relatively to control, for three 
independent experiments. Statistically significant values compared to control are as follows: *p <0,05, 
**p <0,01, ***p <0,001. (CT=1) 
 
 
Results obtained from gene expression analysis demonstrated that the induction on 
intracellular IL-1b mRNA expression, after the stimulation required for inflammasome 
activation with LPS or LPS and ATP, was, indeed, correlated with its secretion via 
exosomes (Fig. 3).  
 
Moreover, in 2007 Valadi and colleagues reported that exosomes were also able to 
deliver functional mRNA to target cells that then translated it into protein, suggesting 
the existence of a transfer of genetic information between cells22. Based on that 
information we decided to investigate if unstimulated THP-1 cells were able to amplify 
this pro-inflammatory signal after incubation with the exosomes isolated from cells 
treated for inflammasome activation (LPS followed by ATP). ELISA assays were 
performed to evaluate the modulation on intracellular and total medium levels of IL-1b 
(Fig. 4). 
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Figure 4 – Increase in IL-1b levels after exosome transfer. THP-1 cells were incubated with or without 
exosomes (24h) isolated from the medium of cells stimulated with LPS and ATP (CM). Intracellular (cells) 
and culture medium (TM) levels of IL-1b were determined by ELISA. Data represents as the means of 
fold induction ± S.D relatively to control, for three independent experiments. Statistically significant 
values compared to control are as follows: **p <0,01. 
 
The results presented in Figure 4 show that incubation of THP-1 cells with IL-1b-mRNA 
containing exosomes leads to a dramatic increase in the amount of IL-1b produced and 
secreted by cells cultured in this conditioned medium. This data, proves that their up-
take is enough to modulate pro-inflammatory responses without the need for any 
further immune challenge. Altogether, the results obtained up to this point 
demonstrate that inflammatory stimuli induces the release, by THP-1 monocytes, of 
exosomes containing both mRNA and the cytokine IL-1b, which can further “spread” 
this pro-inflammatory response throughout the organism. 
 
Nonetheless, a main goal of this project was to find a mechanism capable of reducing 
the secretion of this “pro-inflammatory” exosomes. On that account, there was a 
report by Colombo et al. where they presented evidence that in K562 cells, stimulation 
of autophagy induced the convergence between MVBs and autophagosomes, which 
also inhibited exosome secretion20. So we considered using that approach as a means 
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of dampening the secretion of IL-1b-containing exosomes by THP-1 monocytes after 
inflammasome activation. 
 
It has been described that one of the pathways of IL-1b secretion after inflammasome 
activation is based on secretory autophagy, which is a mechanism based on the release 
of autophagosomes17. Furthermore, serum starvation reportedly induces not only the 
commonly known degradative autophagy that leads to autophagosomal degradation in 
the lysosome, but also up-regulates this recently discovered secretory pathway. 
However, it was suggested that incubation with rapamycin only induces conventional 
macro-autophagy18, and since our intent was to impair exosome release by divergence 
of MVBs to the degradative pathway, we selected the last as the treatment to be used 
after inflammasome activation in order to induce autophagy and potentially confirm 
our hypothesis.  
 
First, in order to optimize the appropriate conditions that lead to autophagy induction, 
we incubated THP-1 cells with rapamycin, for 1 and 3 hours, either in the presence or 
absence of chloroquine. The accumulation of LC3B-II, observed by western blot 
analysis, in the presence of chloroquine (that inhibits both fusion of autophagosome 
with lysosome and lysosomal protein degradation) indicates increased autophagic flux 
(Fig. 5) under these conditions. 
The results presented in Figure 5 demonstrate that THP-1 cells present high 
constitutive autophagy activity, as shown by the accumulation of LC3B-II in cells 
incubated with chloroquine. Furthermore, the accumulation of LC3B-II observed after 
incubation with rapamycin, for 1h or 3h, in the presence of chloroquine, demonstrates 
that autophagy is induced in our experimental conditions. 
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Figure 5 – Induction of the autophagic flux by rapamycin treatment in THP-1 cells. Cells were treated 
with 200nM of rapamycin for 1h or 3h, in the presence or absence of the lysosomal protease inhibitor 
chloroquine (100 µM) added for the last 30 min of treatment. Protein lysate was collected and analyzed 
for LC3B using Western blot analysis to detect autophagy flux. To ensure equal protein loading between 
samples, the membranes were stripped and reprobed with a GAPDH antibody. The immunoblot shown 
is representative of three independent experiments. 
 
According to our hypothesis, stimulation of autophagic flux, that was shown to impair 
exosome secretion in another model, can prevent the release of IL-1b-containing 
exosomes by cells treated with LPS and ATP, used as inflammasome activators. To 
further determine whether exosome secretion after inflammasome activation could be 
inhibited by treatment with rapamycin, THP-1 monocytes were incubated with LPS and 
ATP, as described above, then washed and replated in fresh medium (FM) with or 
without rapamycin (Rap), for 1h or 3h additional hours, after which exosome samples 
were isolated from each culture and quantified after flow cytometry analysis using 
anti-CD63 magnetic beads. The data presented in Figure 6, demonstrates that 
rapamycin treatment results in a significant decrease in the amount of exosomes 
secreted by THP-1 monocytes, previously activated to induce the expression and 
maturation of IL-1b, as well as the release of exosomes (Fig. 1 - B). 
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Figure 6 - Modulation of exosome release by autophagy induction, after inflammasome activation. 
After THP-1 treatment with LPS and ATP, cells were washed and replated in fresh medium (FM) with or 
without rapamycin (Rap), for 1h or 3h additional hours. Exosomes were captured by anti-CD63 magnetic 
beads and stained with plasma membrane marker WGA-PE, and total number of exosome-postive 
counts was obtained by flow-cytometry. Data are represented as the means of fold induction ± S.D. 
relatively to cells cultured in the presence of LPS and ATP and in the absence of rapamycin, for three 
independent experiments. Statistically significant values compared to same time of culture are as 
follows: **p <0,01. 
  
Although basal autophagy has been consistently reported to be essential for 
preventing inflammasome activation4, the effect of its stimulation in cells whose 
inflammasome has been already fully activated is still not as clear. Thus, here we also 
intended to investigate the consequences of up-regulating the autophagic flux on the 
modulation of IL-1b production (which is the main consequence of inflammasome 
activation) by THP-1 cells that were previously incubated with LPS and ATP. ELISA 
measurements of IL-1b levels revealed that rapamycin treatment had a stastically 
significant, yet modest, effect on reducing intracellular cytokine leves (Fig. 7 - CELLS).  
Nontheless, this down-modulatory mechanism showed to be more powerful in 
decreasing the total secretion of IL-1b and, speacialy, its secretion via exosomes (Fig. 7 
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– TM; EXO), agreeing with our previous results which showed that induction of 
autophagy reduces the number of exosomes released to the extracellular medium (Fig. 
6). Taken together these results demonstrate that induction of autophagy, by 
rapamycin not only inhibits IL-1b production but also its release through exosomes. 
 
 
 
 
 
 
 
 
Figure 7 - Modulation of IL-1b production by autophagy induction, after inflammasome activation. 
After activation of IL-1b production by THP-1 treatment with LPS and ATP, cells were washed and 
replated in fresh medium (FM) with or without rapamycin (Rap), for 1h or 3h additional hours. 
Intracellular (cells), total release to the medium (TM) and secretion via exosomes (EXO) of the pro-
inflammatory cytokine IL-1b were determined by ELISA. Data are represented as the means of fold 
induction ± S.D. relatively to cells cultured in the presence of LPS and ATP and in the absence of 
rapamycin, for three independent experiments. Statistically significant values compared to same time of 
culture are as follows: *p <0.05, **p <0.01, ***p <0.001.  
 
We further pursued to explore if the induction of autophagic flux, after inflammasome 
activation, was able to decrease intracellular levels of IL-1b mRNA, and also if that was 
associated with a reduction of the cytokine mRNA concentration in the exosomes 
released by THP-1 monocytes.  
Consistent with protein data (Fig. 7), RT-PCR analysis of gene expression, preformed as 
described previously, showed that rapamycin treatment down-regulated intracellular 
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expression of IL-1b mRNA (Fig. 8 - CELLS), although the decrease in exosomal 
concentration levels of the same mRNA was not as strong (Fig. 8 – EXO). 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 – Modulation of IL-1b mRNA levels by autophagy induction, after inflammasome activation. 
After activation of IL-1b mRNA expression by THP-1 treatment with LPS and ATP, cells were washed and 
replated in fresh medium (FM) with or without rapamycin (Rap), for 1h or 3h additional hours. RT-PCR 
results of the modulation of IL-1b mRNA levels in cells and in exosomes (EXO) isolated from culture, 
after treatment. Data are represented as the means of fold induction ± S.D. relatively to cells cultured in 
the presence of LPS and ATP and in the absence of rapamycin, for three independent experiments. 
Statistically significant values compared to same time of culture are as follows: **p <0,01, ***p <0,001 
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Sulpemmentary Figure: 
 
 
 
 
 
 
 
 
 
 
Figure S1 – Representative graph of flow cytometry analysis of exosome count change after THP-1 
treatment with LPS and ATP, flowed by autophagy induction with rapamycin. Exosomes from each 
sample were capture by anti-CD63 magnetic beads. The bead-exosome complexes (positive counts) 
were stained with the plasma membrane marker WGA-PE to distinguish from exosome-free bead 
counts. Data collected from these experiments was use to quantify the modulation of exosome count 
modulation by inflammasome activation or autophagy induction after immune challenge. 
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Discussion: 
The data presented in this work shows that activation of the inflammasome with LPS 
and ATP stimulated production and release of IL-b. Moreover, we demonstrate that 
treatment of THP-1 cells with LPS and ATP leads to exosome secretion. Interestingly, 
we observed that the increase in the amount of exosomes released after addition of 
ATP, was much higher than the increase in the concentration of IL-1b detected in 
exosomes isolated from the supernatant of cells cultured in the same conditions. This 
finding may indicate that for undifferentiated THP-1 cells, ATP treatment induces the 
release of exosomes containing IL-1b, but also stimulates the secretion of this cytokine 
through another pathway. 
Surprisingly, we found that those exosomes secreted upon activation of the 
inflammasome contained not only the cytokine, but also IL-1b mRNA. This finding is of 
particular relevance, since it clearly highlights their importance in the physiological 
context of inflammasome-associated diseases, linked to increase levels of IL-1b. 
Indeed, these vesicles could thus prove to be part of a mechanism of facilitating the 
dissemination of inflammatory responses to other cells that did not directly contact 
with the danger signals, during immune challenge. To investigate the potential transfer 
of genetic information between cells via exosomes, which would provide an alternative 
pathway of efficient and rapid translation and maturation of IL-1b, we incubated 
unstimulated THP-1 monocytes with exosomes isolated from cells treated with LPS and 
ATP, after which we evaluated the production of the cytokine. The results obtained 
demonstrate a strong up-regulation of IL-1b after the addition of IL-1b mRNA-
containing exosomes, suggesting that exosomes constitute a carrier for the transport 
of IL-1b mRNA that can be translated in cells localized far from the stimulated, mRNA 
producing, cells. Moreover, to prove that the increase in IL-1b is due to the translation 
of the cytokine’s mRNA, and not a result of the up-take of IL-1b protein carried by 
these vesicles, we should have done a control where we would incubate the cells with 
exosomes and a translation inhibitor (e.g. Cycloheximide) and show that the up-
regulation of IL-1b production was not as strong as without such inhibition. Even so, 
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inhibiting the secretion of vesicles capable of inducing a pro-inflammatory response at 
a distance and without any other immune challenge, might turn out to be a protective 
therapeutic mechanism for diseases associated with exacerbated inflammation. 
In this study, our approach for reducing the secretion of exosomes after 
inflammasome activation was the stimulation of autophagy. The selection of this 
approach was based on a report by Fader et al. (2008) where they presented evidence 
that in K562 cells, induction of the autophagic process led to the convergence between 
MVBs and autophagosomes, which strongly inhibited exosome release20. Here, we also 
observed a marked inhibition of this secretory pathway by rapamycin treatment in 
activated THP-1 monocytes, apparently in a time dependent manner. Nonetheless, 
despite the successful reduction of the number of exosomes released after 
inflammasome activation, and because IL-1b is also exported via autophagy-based 
unconventional secretion, the relationship between stimulation of autophagy and total 
production of IL-1b in the context of inflammasome activation is still quite 
controversial. 
Earlier studies have clearly linked basal autophagy with the inhibition of spurious 
activation of the inflammasome. Since dysfunctional organelles, including 
mitochondria, are removed by autophagosomes, inhibition of autophagy leads to an 
accumulation of ROS-producing mitochondria, which is accompanied by increased 
release of mitochondrial DNA, which are known “danger” signals that activate the 
inflammasome, consequently leading to the release of IL-1b. Moreover, autophagy is 
also involved in the removal of ubiquitinated inflammasomes and pro-IL-1b in 
activated cells. In contrast to the anti-inflammatory effects of basal autophagy, which 
suppresses unscheduled inflammasome activation, the consequences of induced 
autophagy in the secretion of the pro-inflammatory cytokine IL-1b are not as 
consistent4. 
In 2011, Harris et al demonstrated that in mouse macrophages primed with 
particulates and TLR agonists followed by 4h incubation with rapamycin, as well as in 
an LPS challenge in vivo with or without concomitant addition of rapamycin, the 
Discussion 
 
33 
induction of autophagy led to an inhibition the secretion of IL-1b23. Consistently, 
another group (Shi et al. 2011) also found a reduction in amount of IL-1β in the 
supernatants of differentiated THP-1 cells. Indeed, these authors demonstrated that 
induction of autophagy reduced the levels of IL-1b released by cells incubated with the 
NLRP3 inflammasome–inducers uric acid crystals or nigericin, coordinately treated 
either with amino-acid starvation or rapamycin for 6h, when compared to the levels 
found in cells treated only for inflammasome activation24. However, another study 
shows an opposite role for autophagy in modulation of IL-1b release during immune 
challenge. It was reported, by Dupont and colleagues (2011) that stimulation of 
autophagy by serum starvation, while activating the inflammasome with different 
danger signals, for 1h in LPS-primed mouse macrophages leads to an increase in the 
export of IL-b to the extracellular medium. The up-regulated export of IL-1b was found 
to happen as a result of an increase in its release via secretory autophagy, for which 
the pro-inflammatory cytokine is prototypical example of the newly found 
unconventional manifestation of autophagy25. 
The inconsistency of the previously described results may be due to the existence of 
temporal or treatment differences required to activate either degradative or secretory 
autophagy. It was indeed suggested that although serum starvation was capable of 
stimulating both pathways, rapamycin only induced the degradative autophagic 
process20. Still, our main goal in this study was to test the stimulation of autophagy as 
a means of dampening exosome secretion upon inflammasome activation, thus 
reducing the amplification of inflammation. Therefore, it was important to use a 
strategy that while attempting to inhibit IL-1b-containg exosome release, we were not 
increasing the export of this cytokine by another pathway. It was on that account that 
we chose rapamycin for the stimulation of degradative autophagy, which proved to be 
a treatment capable of reducing intracellular and secreted levels of IL-1b after 
inflammasome activation by THP-1 cells, not interfering with our model of protection 
against inflammation. 
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In summary, we have demonstrated that activation of the inflammasome by treatment 
with LPS and ATP in THP-1 monocytes, induces the secretion of exosomes containing 
the cytokine IL-1b and its mRNA. This secretion is inhibited by autophagy stimulation 
with rapamycin treatment, which also reduces total levels of IL-1b. It would now be 
interesting to access if we could mimic this mechanism of exosome inhibition after 
inflammasome activation in vivo, decreasing serum levels of IL-1b-containing 
exosomes and if that would be an effective mechanism to reduce the phenotypic and 
pathological consequences usually associated with elevated production of this pro-
inflammatory cytokine. Moreover, we believe that our study opens a new therapeutic 
avenue for diseases associated with elevated secretion of exosomes, not only in the 
context of inflammation.  
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